Emerging Microbes & Infections

As an international peer reviewed journal, the mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and thus EMI is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years.EMI will cover relevant topics of critical biological and clinical value including, but not limited to:epidemic surveillance;clinical manifestation;diagnosis and management;cellular and molecular pathogenesis;innate and acquired immune responses between emerging microbes and their hosts;drug discovery, andvaccine developmentEMI will serve microbiologists, clinicians, public health workers, drug and vaccine developers, as well as policy makers by providing them with updated knowledge encompassing microbes and infections emerging in different countries and regions throughout the world.

《新兴微生物与感染》(EMI)作为一份国际同行评议期刊，其使命是提供一个新的综合论坛，以便及时传播收集到的大量有关微生物和感染的信息，特别是那些与日益增加的生物学和临床意义以及致病频率相关的信息。这些信息的绝对数量和复杂性已经超出了现有专业期刊的规模和范围，因此EMI致力于弥合发达国家和发展中国家科学界之间的差距。近年来，大多数新兴微生物和感染都发生在发展中国家。EMI将涵盖具有重要生物学和临床价值的相关主题，包括但不限于:疫情监控;临床表现;诊断和管理;细胞和分子发病机制;新生微生物及其宿主之间的先天和后天免疫反应;药物发现,疫苗开发EMI将为微生物学家、临床医生、公共卫生工作者、药物和疫苗开发人员以及决策者提供最新的知识，包括世界各地不同国家和地区出现的微生物和感染。